Fundraising Fox
🦊/People
Sign in

Annie Mitsak

Investor

Partner at Cure Ventures · Principal at Omega Funds · Board director at Triton Therapeutics, Inc. · Board director at Alessa Therapeutics

Boston, Massachusetts, United States

Find your path to Annie

658 people in our graph share verified history with Annie — schools, employers, funds. One of them is your warm intro.

Noubar AfeyanunlockedAnnie: together at Massachusetts Institute of Technology (MIT) (2012–2015)
×3Annie: together at University of Virginia
Annie: together at Massachusetts Institute of Technology (MIT)
Annie: together at University of Michigan

About

Partner with over ten years in academic licensing and venture investing. Previously spent over six years on the Omega Funds investment team and worked at MIT's Technology Licensing Office.

Contact· published on Annie's own website

Board director at Triton Therapeutics, Inc.

Intro paths

→

In turn, Annie can intro founders to Triton Therapeutics, Inc.'s investors below.

Triton Therapeutics, Inc.'s investors · 2

Canaan PartnersStamford · $500K – $20M checks · since 2025Cure VenturesBoston · since 2025

Board director at Alessa Therapeutics

Intro paths

→

In turn, Annie can intro founders to Alessa Therapeutics's investors below.

Alessa Therapeutics's investors · 4

Cure VenturesBoston · since 2025Mission Bay CapitalSan FranciscoMission BiocapitalSan Francisco · $500K checks · since 2025National Institutes of Health (NIH)since 2021

Co-founders at Alessa Therapeutics

PMPamela Munster
Pamela MunsterFounder, Director & Chief Scientific Advisor

Experience

  1. Triton Therapeutics, Inc.Board Membercurrent2025 — present
  2. Alessa Therapeutics, Inc.Board Membercurrent2025 — present
  3. Cure VenturesPartnercurrent2023 — presentBoston, Massachusetts, United States
  4. Photys TherapeuticsBoard Observer2021 — 2022
  5. Rectify PharmaBoard Observer2021 — 2022
  6. Scorpion TherapeuticsBoard Observer2021 — 2022
  7. Anjarium BiosciencesBoard Observer2021 — 2022
  8. Omega FundsPrincipal2019 — 2022
  9. Omega FundsAssociate2015 — 2019Boston, MA
  10. Ikena OncologyBoard Observer2020 — 2021
  11. Checkmate PharmaceuticalsBoard Observer2020
  12. Trevi Therapeutics, Inc.Member Board Of Directors2018 — 2020
  13. Massachusetts Institute of Technology (MIT)Associate Technology Licensing Officer2014 — 2015
  14. Massachusetts Institute of Technology (MIT)Technology Licensing Associate2012 — 2014Cambridge, MA
  15. Nelsen BiomedicalIndependent Consultant2015
  16. University of MichiganPostdoctoral fellow2012Ann Arbor, MI
  17. Kaplan Test Prep and AdmissionsGRE Instructor2007
  18. Penn State UniversityResearch Assistant2005
  19. Johns Hopkins UniversityResearch Assistant2004Baltimore, MD

Skills & more

Contract NegotiationDrafting AgreementsPeer MentoringPatent Portfolio AnalysisBiomedical EngineeringLicensing

From Annie's professional profile.

Investments

Per SEC Form D filings.

Colleagues at Cure Ventures

Albert J. Robichaud
Partner at Cure Ventures
Bill Amsbaugh
CTO and Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Jeffrey M. Jonas
Partner at Cure Ventures

Network6

Alex Delbridge
Senior Associate at Omega Funds
Bernard Davitian
Partner at Omega Funds
Francesco Draetta
Managing Director at Omega Funds
Katie Kerfoot
Vice President at Omega Funds
Michael Powell
Partner at Omega Funds
Thomas Goebel
Principal at Omega Funds

Investors connected to Annie in public investor directories — a warm-intro map.

Frequently asked questions

Who is Annie Mitsak?
Partner with over ten years in academic licensing and venture investing. Previously spent over six years on the Omega Funds investment team and worked at MIT's Technology Licensing Office.
Where does Annie Mitsak work?
Annie Mitsak is Partner at Cure Ventures and Board director at Triton Therapeutics, Inc. and Board director at Alessa Therapeutics.
What boards does Annie Mitsak sit on?
Annie Mitsak holds tracked board seats at Alessa Therapeutics, Triton Therapeutics, Inc..
Where did Annie Mitsak go to school?
Annie Mitsak studied at University of Michigan (PhD, Biomedical Engineering); University of Michigan (M.S., Biomedical Engineering); University of Virginia (BS, Biomedical Engineering).

Same school

Shared employers